Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Sinusobliquus Stent System

Research Leaders

9 sponsors active, led by First Affiliated Hospital of Zhejiang University

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Unknown1
Completed1
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (3)

Research Network

Common Treatments

  • Sinusobliquus Stent System1
  • Aspirin1
  • Rivaroxaban1

Active Sponsors

  • First Affiliated Hospital of Zhejiang University1
  • Taizhou First People's Hospital1
  • The Central Hospital of Lishui City1
  • Shanghai Zhongshan Hospital1
  • Optimed Medizinische Instrumente GmbH1

Top Investigators

Related Conditions

  • Postthrombotic Syndrome1
  • Iliac Vein Thrombosis1
  • Iliac Vein Obstruction1
  • Deep Vein Thrombosis1
  • Iliac Vein Stenosis1

Activity Timeline